{"Clinical Trial ID": "NCT02835625", "Intervention": ["INTERVENTION 1:", "Tomosynthesis digital mammary", "- Digital breast synthesis + synthetic mammography (DBT)", "The DBT was read independently by two radiologists and a consensus meeting decided to remember the woman or not.", "Women selected for subsequent assessment (positive screening) were recalled.", "Tomosynthesis digital breast + synthetic mammography: Two-vision tomosynthesis performed with GE SenoClaire 3D breast tomosynthesis.", "INTERVENTION 2:", "Digital mammography", "The digital mammograms were read independently by two radiologists. A consensus meeting decided to remember the woman or not.", "Women selected for subsequent assessment (positive screening) were recalled.", "Digital mammography: two-view digital mammography made with the GE SenoClaire 3D breast tomography."], "Eligibility": ["Incorporation criteria:", "Informed consent", "- Exclusion criteria:", "Breast implants"], "Results": ["Performance measures:", "Number of participants with breast cancer determined by the screen", "Comparison of breast cancer rates detected by screening in tomosynthesis with numerical mammography, as conducted through a population-based screening program.", "Time limit: 36 months from the start of the trial", "Results 1:", "Title of the arm/group: Digital breast tomosynthesis", "Description of the arm/group: Digital breast synthesis + synthetic mammography (DBT)", "The DBT was read independently by two radiologists and a consensus meeting decided to remember the woman or not.", "Women selected for subsequent assessment (positive screening) were recalled.", "Tomosynthesis digital breast + synthetic mammography: Two-vision tomosynthesis performed with GE SenoClaire 3D breast tomosynthesis.", "Total number of participants analysed: 14380", "Type of measure: Number of participants", "Unit of measure: Participants 95 0.7%", "Results 2:", "Title of the arm/group: Digital mammography", "Description of the Arm/Group: Digital mammograms were read independently by two radiologists. A consensus meeting decided to remember the woman or not.", "Women selected for subsequent assessment (positive screening) were recalled.", "Digital mammography: two-view digital mammography made with the GE SenoClaire 3D breast tomography.", "Total number of participants analysed: 14369", "Type of measure: Number of participants", "Unit of measure: Participants 87 0.6%"], "Adverse Events": ["Undesirable Events 1:", "Total: 0/14734 (0.00 per cent)", "Adverse Events 2:", "Total: 0/14719 (0.00 per cent)"]}